Responses
Clinical and epidemiological research
Concise report
Clinical response and tolerability to abatacept in patients with rheumatoid arthritis previously treated with infliximab or abatacept: open-label extension of the ATTEST Study
Compose a Response to This Article
Other responses
No responses have been published for this article.